The competition for the core technology of flexibl

2022-10-18
  • Detail

The competition for the core technology of "soft packaging" in the implementation of genetic testing is intensifying

release date: Source: China Chemical Instrument editor: Arnold browse times: 2347 copyright and disclaimer

core tip: read today's headlines, one of the focuses that must be mentioned is that Chinese parents have promoted the prosperity and development of genetic testing business, because they want to discover the talents of their children. This article strives to promote the development of the gene testing market in China and understand the needs of exhibitors. At the same time, it also makes the chaos of the gene testing market appear on the paper

[China Packaging News] reading today's headlines, we have to mention that Chinese parents have boosted the prosperity and development of genetic testing business, because they want to discover their children's talents. This article strives for the development of the gene testing market in full swing in China. At the same time, it also makes the chaos of the gene testing market appear on the paper

the competition for the core technology of "soft packaging" in the implementation of gene testing is becoming more and more intense

when reading, we were told: "Gene is a functional fragment of DNA molecule, the basic unit of genetic information, and the most basic factor that determines all biological species. Where there is life, there are genes. The existence and decline of all life are determined by genes, including a person's appearance, height, weight, skin color, personality and so on. So, what is gene detection?

gene detection is through blood The technology of detecting DNA in fluids, other body fluids, or cells; Individuals can be determined, and their group (ancestral) characteristics can also be determined through group comparison. Looking for a needle in a haystack, narrow the area first, and then detect individuality

gene detection technology, as a major innovation in the development of contemporary medicine, has been included in the "new health technology benefiting the people project". In order to speed up the development and popularization of gene testing technology and promote the application of gene testing technology in the prevention and treatment of major diseases, many provinces across the country have issued supporting policies. Recently, there has been a growing call for the inclusion of genetic testing in medical insurance. The popularity of genetic testing is no longer far away

from the strategic commanding height, according to relevant data, before 2030, China will invest 600 million yuan in the field of precision medicine, but at that time, due to the immature development of large-scale integrated circuits. In January this year, CIC released the "prediction report on the gene testing industry from 2017 to 2021", which put forward good news. In addition to more than 150 enterprises and institutions engaged in gene sequencing related businesses in the country, more and more biological companies and institutions have joined the team of the gene testing service industry

with the development of precision medicine, a variety of testing services suitable for healthy people and ordinary families will appear in the future. For third-party testing institutions, core competitiveness does not only refer to core technology, but efficient and accurate personalized services may be the decisive factor causing competitiveness differentiation. For consumers, what they face directly is not the core technology, but the "comfort" brought by this service. How to provide efficient and accurate services is the most attractive "soft packaging" provided by third-party testing institutions for consumers. Here, the service chain includes the ground spring qb/t 3884 ⑴ 999, which obtains information from the early stage, selects institutions, collects test samples, and timely feeds back the genetic test reports and interpretation reports to consumers. The considerate service of these details is a word-of-mouth publicity for the testing institutions

on the whole, the lack of core technology has been initially recognized by MiCasa, and the competition in the talent deletion gene testing market is becoming increasingly fierce. In the future, the competition for core services will lead to the intensification of this talent competition. This contradiction between high cost and low talent utilization may open a new situation through platform cooperation. Technology sharing, talent sharing, auxiliary and personalized services and experiences will help to build a unique brand and irreplaceable testing organization

Copyright © 2011 JIN SHI